Wednesday, January 26, 2005
Ingen Technologies Receives Endorsement by the American Academy of Balance Medicine
�
For Immediate Release:
Calimesa, CA- January 26, 2005: Ingen Technologies (OTC: IGTN) announced today that it has received exclusive endorsement for the Secure Balance� product line from the American Academy of Balance Medicine.� The Company introduced the Secure Balance� program at the annual meeting for the American Academy of Balance Medicine on January 22, 2005.
Jacob Green, M.D., President of the American Academy of Balance Medicine, stated, “The American Academy of Balance Medicine is an organization open to any and all healthcare providers interested in the amelioration of suffering in patients that have difficulty with balance, suffer from vertigo, and subsequent falls.� Our Board Members and the Academy recognize the clinical value of the Secure Balance� products to assist our patients in regaining their balance.”
The Company has since experienced an increase in new orders for the $53,000 Secure Balance� program.� The Company sold several systems to physician attendees, and expects to make delivery in February, with a continued increase in sales and revenues.
Scott Sand, CEO and Chairman of Ingen Technologies, said,� “We had a positive reception from the many physicians and other clinicians who attended the annual meeting in Charleston. Our products are superior to anything else in the market today.”
About Ingen Technologies
Ingen Technologies, Inc. is a public company trading on OTC: IGTN. In business since 1999, Ingen Technologies is a growth-oriented technology company that offers a diverse and progressive service and product line.
The Company’s flagship products are its BAFI�, GasAlert� and OxyAlert� products, the world’s first wireless digital low gas warning system for pressurized gas cylinders. The BAFI� received a US Patent on October 24th, 2000, Patent No. 6,137,417. BAFI�, now in its second generation, is an accurate and cost-effective, real-time pressurized gas warning system that will alert users when gas levels are approaching empty.
The BAFI� line has multiple applications, inclusive but not limited to, the Medical Industry, Home Consumer, Residential Development Industry, Safety & Protection (fire and police), Aircraft Industry, and the Recreational Vehicle Industry. BAFI� meets or exceeds regulatory compliance of this type of product and is completed and in production.
The successful Secure Balance� program is equipment, training and an educational support system available to physicians throughout the United States. During the initial twelve months, the Secure Balance� system generated approximately $1 million in revenues for Ingen and is now being aggressively marketed throughout the United States. More recently, the company’s sales have increased in proportion to the expansion of the Company’s marketing network. Its marketing strength is based upon superior products and an experienced, professional team.
The Secure Balance� program offers the most sophisticated clinical products for vestibular function testing and balance therapy compared to any of their competitors. With more than two million people visiting their doctor each year complaining of dizziness and vertigo; Secure Balance � can substantially help patients regain their balance and decrease the number of fall related injuries. The elderly population is expected to double over the next decade and comprise the majority of balance disorder patients.
�
For more information, visit: www.otcfn.com/igtn and www.ingen-tech.com
Investor Relations Contact: �Scott R. Sand, C.E.O & Chairman
�����Ingen Technologies, Inc.
�����285 E. County Line Road
�����Calimesa, CA 92320
�����800-259-9622
�����951-675-3266
�����800-777-1186 FAX
�����[email protected]
�����Rick McCaffrey, Investor Relations
�����OTC Financial Network
�����781-444-6100 x625
�����781-444-6101 FAX
�����[email protected]
Safe Harbor for Forward-Looking Statements:� This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
Download this article in PDF format: IGTNAABMmeeting012605d1.pdf
